Simeprevir added to peginterferon and ribavirin lessens time with fatigue, depressive symptoms and functional limitations in patients with chronic hepatitis C compared with peginterferon and ribavirin: results from 1161 patients in the QUEST-1, QUES
about
Direct-acting antivirals for chronic hepatitis C.Review article: safety and tolerability of direct-acting anti-viral agents in the new era of hepatitis C therapy.The impact of hepatitis C virus outside the liver: Evidence from Asia.Patient-reported outcomes with direct-acting antivirals for the treatment of chronic hepatitis C: current knowledge and outstanding issues.Simeprevir plus sofosbuvir (12 and 8 weeks) in hepatitis C virus genotype 1-infected patients without cirrhosis: OPTIMIST-1, a phase 3, randomized study.Simeprevir plus peginterferon/ribavirin for HCV genotype 1-infected treatment-naïve patients in China and South Korea.Direct-acting antivirals for chronic hepatitis C
P2860
Q34557595-CEC46C56-49AB-48A9-8C42-B3C0E0E83DB3Q38703524-E28B3AA1-667B-483E-A3CF-09174F7B919EQ38982462-35C7D0E7-648A-42BC-B278-7E160D16BC2DQ39002714-F1C66904-BC0E-4DBE-934D-3D980E96403CQ40821688-EB7C847A-80FC-47F7-A084-2F062627C644Q40829783-9259D4CD-FBEC-436F-BF34-5D39D2D0B2F5Q57389418-B2FDB56A-971A-45F5-9370-4B2BC0B2D673
P2860
Simeprevir added to peginterferon and ribavirin lessens time with fatigue, depressive symptoms and functional limitations in patients with chronic hepatitis C compared with peginterferon and ribavirin: results from 1161 patients in the QUEST-1, QUES
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Simeprevir added to peginterfe ...... patients in the QUEST-1, QUES
@en
type
label
Simeprevir added to peginterfe ...... patients in the QUEST-1, QUES
@en
prefLabel
Simeprevir added to peginterfe ...... patients in the QUEST-1, QUES
@en
P2093
P2860
P356
P1476
Simeprevir added to peginterfe ...... patients in the QUEST-1, QUES
@en
P2093
R Arbuckle
P2860
P304
P356
10.1111/JVH.12365
P577
2014-12-09T00:00:00Z